期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

抗信号识别颗粒抗体肌病研究进展 被引量：2

原文传递
导出
摘要 抗信号识别颗粒（signal reognition particle，SRP）抗体肌病是一种以出现血清抗SRP抗体为特点的免疫性坏死性肌病［1］。抗SRP抗体首次于1986年在1例多发性肌炎患者血清中检测到［2］。
作者 王璐 王朝霞 张巍 袁云
机构地区 北京大学第一医院神经内科
出处 《中华神经科杂志》 CAS CSCD 北大核心 2012年第11期812-814,共3页 Chinese Journal of Neurology
关键词 信号识别颗粒 坏死性肌病 颗粒抗体 多发性肌炎 SRP 免疫性 血清
分类号 R746 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献19

  • 1Miller T, A1-Lozi MT, Lopate G, et al. Myopathy with antibodies to the signal recognition particle: clinical and pathological features. J Neurol Neurosurg Psychiatry, 2002,73:420-428.
  • 2Reeves WH, Nigam SK, Blobel G. Human autoantibodies reactive with the signal-recognition particle. Proc Nalt Acad Sci U S A , 1986,83:9507-9511.
  • 3Targoff IN, Johnson AE, Miller FW. Antibody to signal recognition particle in polymyositis. Arthritis Rheum,1990, 33: 1361-1370.
  • 4Hoogendijk JE, Amato AA, Lecky BR, et al. 119th ENMC international workshop : trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord, 2004, 14: 337-345.
  • 5Suzuki S, Satoh T, Sato S, et al. Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies. Rheumatology, 2008, 47: 1539-1542.
  • 6Leung E, Brown JD. Biogenesis of the signal recognition particle. Biochem Soc Trans ,2010,38 : 1093-1098.
  • 7Saraogi I, Shan S. Molecular mechanism of co-translational protein targeting by the signal recognition particle. Traffic, 2011, 12 : 535-542.
  • 8Valiyil R, Caseiola-Rosen L, Hong G, et al. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series. Arthritis Care Res (Hoboken), 2010, 62 : 1328-1334.
  • 9Satoh T, Okano T, Matsui T, et al. Novel autoantibodies against 7SL RNA in patients with polymyositis/dermatomyositis. J Rheumatol, 2005, 32 : 1727-1733.
  • 10Hengstman GJD, ter Laak HJ, Vree Egberts WT, et al. Anti- signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis, 2006, 65 : 1635-1638.

二级参考文献35

  • 1朱铁山,李军,俞宝田.肌炎特异性抗体和特发性炎性肌病[J].医学综述,2005,11(2):140-141. 被引量：1
  • 2袁云.骨骼肌疾病的临床病理诊断[J].中华神经科杂志,2006,39(8):505-507. 被引量：12
  • 3Bataller L, Dalmau JO. Paraneoplastic disorders of the central nervous system : update on diagnostic criteria and treatment. Semin Neurol, 2004, 24:461-471.
  • 4Rudnicki SA, Dalmau J. Paraneoplastic syndromes of the peripheral nerves. Curr Opin Neurol, 2005,18: 598-603.
  • 5Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a populationbased study. Lancet, 2001, 357: 96-100.
  • 6Levine SM. Cancer and myositis: new insights into an old association. Curr Opin Rheumatol, 2006, 18:620-624.
  • 7Spirin NN, Bulanova VA, Pizova NV, et al. Peripheral nervous system lesion syndromes and the mechanisms of their formation in connective tissue diseases. Neurosei Behav Physiol, 2007,37 : 1- 6.
  • 8Cavaletti G, Bogliun G, Marzorati L, et al. The incidence and course of paraneoplastic neuropathy in women with epithelial ovarian cancer. J Neurol, 1991,238: 371-374.
  • 9Agarwal V, Singh R, Wiclaf, et al. A clinical, electrophysiologieal, and pathological study of neuropathy in rheumatoid arthritis. Clin Rheumatol, 2008, 27: 841-844.
  • 10Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med, 1997, 337: 1512-1523.

共引文献7

同被引文献20

  • 1Hoogendijk JE, Amato AA, Lecky BR, et al. l l9th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands [ J]. Neuromuscul Disord, 2004,14 ( 5 ) : 337-345.
  • 2Kissel JT, Halterman RK, Rammohan KW, et al. The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis[ J]. Arch Neurol, 1991, 48( 1 ) : 26-30.
  • 3Miller T, A1-Lozi MT, Lopate G, et al. Myopathy with antibodies to the signal recognition particle: clinical and pathological tatures [J]. J Neurol Neurosurg Psychiatry, 2002, 73(4) : 420-428.
  • 4Gherardi RK. Pathogenic aspects of dernmtomyositis, polymyositis and overlap myositis[J]. Presse Med, 2011, 40(4 Pt 2) : 209- 218.
  • 5Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis[J]. Laneet, 2003, 362 ( 9388 ) :971-982.
  • 6Pavlath GK. Regulation of class MHC expression in skeletal musele: deleterious effect of aberrant expression on myogenesis [J]. J Neuroimmunol, 2002, 125(1-2) : 42-50.
  • 7Panieker JB, Chaeko G, Patil AK, et al. hnmunohistoehemieal differentiation of inflammato myopathies [ J ]. Neurol India, 2011 , 59(4) : 513-520.
  • 8Choi JH, Park YE, Kim SI, et al. Differential immunohistologieal features of inflammatory myopathies and dysferlinopathy [ J ]. J Korean Med Sci, 2009, 24(6) : 1015-1023.
  • 9Louboutin JP, Navenot JM, Rouger K, et al. S-protein isexpressed in necrotic fibers in Duchenne muscular dystrophy and polymyositis [ J]. Muscle Nerve, 2003, 27 (5) : 575-581.
  • 10Spuler S, Engel AG. Unexpected sarcolemmal complement membrane attack complex deposits on non-necrotic muscle fibers in nmscular dystrophies[ J]. Neurology, 1998, 50( 1 ) : 41-46.

引证文献2

二级引证文献5

中华神经科杂志
2012年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部